Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2013; 19(46): 8714-8721
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8714
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8714
Figure 1 Immunodetected differential LGR5 expression in gastric tissues, following progression of tumorigenesis, and in distant metastases.
Representative samples are shown from leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5)- (A) and LGR5+ (B) normal gastric normal tissues, LGR5- (C) and LGR5+ (D-F) gastric cancer (GC) tissues with weak, moderate and strong expression, LGR5+ gastric intestinal metaplasia and dysplasia tissues (G, H), and LGR5+ lymph node and liver metastases (I, J). A, C-J: Magnification: × 200; B: Magnification: × 100.
- Citation: Zheng ZX, Sun Y, Bu ZD, Zhang LH, Li ZY, Wu AW, Wu XJ, Wang XH, Cheng XJ, Xing XF, Du H, Ji JF. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis. World J Gastroenterol 2013; 19(46): 8714-8721
- URL: https://www.wjgnet.com/1007-9327/full/v19/i46/8714.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i46.8714